abrdn Life Sciences Investors (HQL) Government Trades - Latest Congressional Stock Transactions
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
top performing (HQL) trades
Recent abrdn Life Sciences (HQL) Trades by Congress Members
See the most up-to-date abrdn Life Sciences trades disclosed by US lawmakers, including purchase and sale amounts, transaction dates, and reporting details. View the most recent abrdn Life Sciences trades made by congress members.
 Thomas R. CarperSenate (D-DE) | $1K - $15K | stock | Sale | Nov 03, 2022 | Oct 04, 2022 | Senate |
